Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8535 |
High Similarity |
NPD1934 |
Approved |
0.8491 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8491 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8481 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8408 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8365 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8364 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8289 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8282 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.825 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.825 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8242 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8242 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8242 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.821 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8205 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8182 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8158 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8141 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8141 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8137 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8107 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8089 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8089 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8089 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8075 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8067 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8063 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8061 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8059 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8052 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8038 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8012 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7988 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7976 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7975 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7961 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7941 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7895 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7885 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7882 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7849 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7824 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7815 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7806 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7803 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7803 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7771 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7756 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7751 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD37 |
Approved |
0.7725 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7712 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7711 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7711 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7711 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7706 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD920 |
Approved |
0.764 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7633 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7632 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7628 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD943 |
Approved |
0.7593 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7588 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.758 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7561 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7556 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7546 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7543 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7533 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7531 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD919 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7228 |
Approved |
0.75 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7472 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7458 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7458 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7443 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7421 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7421 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7371 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7349 |
Intermediate Similarity |
NPD2649 |
Approved |
0.7349 |
Intermediate Similarity |
NPD2651 |
Approved |
0.7348 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7284 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7273 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7235 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7205 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7176 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD3972 |
Approved |
0.717 |
Intermediate Similarity |
NPD6653 |
Approved |
0.716 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7124 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7112 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7102 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7099 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7089 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD17 |
Approved |
0.7081 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7077 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7077 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7073
|
Intermediate Similarity |
NPD7003 |
Approved |